Target intelligence / Profile preview

DNA polymerase III PolC-type subunit (PolC)

Target
PolC
Molecular classification
Enzyme, DNA polymerase, C-family DNA polymerase, Replicative enzyme
01

Overview

DNA polymerase III PolC-type subunit is a C-family replicative DNA polymerase that serves as the primary enzyme responsible for chromosomal DNA replication in Gram-positive bacteria, particularly those with low genomic GC content[2][10]. PolC catalyzes rapid DNA synthesis on both leading and lagging strands and possesses intrinsic 3' to 5' exonuclease activity for proofreading, contributing to high-fidelity replication[2][6]. The enzyme contains a unique N-terminal domain and structural features including a β-strand motif in its thumb domain that enables sensing of replication errors up to 8 nucleotides upstream of the active site, facilitating communication with the broader replisome machinery to trigger error correction[5]. PolC is universal among bacteria analyzed to date, making it essential for bacterial viability and representing a validated biological target for potential antimicrobial therapeutic development, though no clinically approved drugs currently target this enzyme[2]. Mutations in the polC gene have been shown to generate hypermutator bacterial phenotypes, suggesting the enzyme's critical role in maintaining genomic stability[8].

Other names
DNA polymerase III alpha subunit (PolC form)PolC-type DNA polymerase IIIC-family replicative polymeraseDNA polymerase III (Gram-positive bacteria form)
02

Mechanism of action

Inhibition of PolC would likely result in: - Inhibition of bacterial DNA replication - Disruption of both leading and lagging strand synthesis - Potential bacterial cell death or growth arrest

03

Biological functions

DNA replication: PolC performs replicative DNA synthesis and is responsible for rapid synthesis of long stretches of DNA on both leading and lagging strandsProofreading: Exhibits 3' to 5' exonuclease activity for error correction during DNA replicationDNA template binding: Contains an oligonucleotide binding (OB) domain that binds the template strand approximately 15-20 nucleotides ahead of the polymerase active siteReplication fidelity: Possesses mechanisms to sense replication errors and communicate with the replisome to trigger proofreading
04

Disease associations

Bacterial infection: Essential for bacterial DNA replication and potential target for antibacterial therapiesHypermutation/genome instability: Mutations in polC can lead to hypermutator phenotypes in bacteria, affecting mutation rates
05

Safety considerations

Selectivity challenges: Any antimicrobial targeting PolC would need to achieve selectivity for bacterial enzymes over eukaryotic DNA polymerases to avoid toxicityEssential gene: PolC is required for replicative DNA synthesis in Gram-positive bacteria, making resistance through loss-of-function unlikely but potential resistance mechanisms through altered enzyme kinetics remain possibleLimited clinical development: No known clinical drugs currently target this enzyme, indicating potential challenges in developing viable therapeutics or suggesting this remains an unexploited target
06

Biomarkers

polC gene mutations: Mutations such as C669Y have been identified in hypermutator strains and could serve as markers for altered replication fidelityBacterial genome GC content: PolC presence correlates with low-GC Gram-positive bacteria, which could inform organism identification

Beyond the preview

Go deeper on DNA polymerase III PolC-type subunit (PolC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA polymerase III PolC-type subunit (PolC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call